Global Tumor Ablation Market to Grow at 10.4% During 2025-2033, Stimulated by Advent of Advanced Procedures

November 28, 2024 | Healthcare

According to the latest report by IMARC Group, titled “Tumor Ablation Market Report by Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation), Mode of Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others), End-User (Hospitals, Cancer Specialty Clinics, and Others), and Region 2025-2033”, the global tumor ablation market size reached USD 1,310 Million in 2024. Tumor ablation is a minimally invasive (MI) surgery, which is utilized in the treatment of bone, liver, kidney and lung tumor. It is also considered as a potential first-line treatment for numerous patients with small hepatocellular carcinomas or benign tumors. During the procedure, a specialized needle-like probe is inserted at the precise location of the tumor and then energy is employed for heating or cooling the tissue to cytotoxic levels. Generally, laser, radio-frequency (RF), and microwave (MW) systems are used for heating the tissue to at least 60 degrees Celsius for maximum efficacy.

Global Tumor Ablation Market Trends:

According to the World Health Organization (WHO), cancer represents one of the leading causes of death across the globe. This can be attributed to sedentary lifestyles, high body mass index, low consumption of fruits and vegetables, and regular consumption of tobacco as well as alcohol. The rising prevalence of cancer, in confluence with benefits offered by MI procedures, such as speedy recovery, less trauma and reduced complications, is strengthening the global tumor ablation market growth. Apart from this, governments of various countries are investing in cancer awareness programs to minimize their healthcare expenditure, which in turn is also impelling the market growth. Furthermore, the advent of technological advancements, such as thermal and laser ablation, irreversible electroporation and High-Intensity Focused Ultrasound (HIFU), is anticipated to boost the market in the coming years. Looking forward, IMARC Group expects the market value to reach USD 3,200 Million by 2033, exhibiting a CAGR of 10.4% during 2025-2033.

Market Summary:

  • Based on the technology, the market has been segmented into radiofrequency (RF) ablation, microwave ablation, cryoablation and others.
  • On the basis of the mode of treatment, the market has been segregated into percutaneous, laparoscopic and surgical ablation.
  • The market has been analyzed on the basis of the application into liver cancer, lung cancer, kidney cancer, bone metastasis and others.
  • Based on the end user, the market has been classified into hospitals, cancer specialty clinics and others.
  • Region-wise, the market has been divided into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has been examined, with some of the key players being Medtronic Public Limited Company, AngioDynamics, Inc., HealthTronics, Inc., NeuWave Medical, Inc., INTIO, Inc., Galil Medical Ltd., Boston Scientific Corporation, SonaCare Medical, LLC, EDAP TMS S.A., Erbe Elektromedizin GmbH, IceCure Medical Ltd., MISONIX Inc., Endocare Inc., CooperSurgical Inc. and B V M Meditech Pvt.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Technology, Mode of Treatment, Mode of Application, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Medtronic Public Limited Company, AngioDynamics, Inc., HealthTronics, Inc., NeuWave Medical, Inc., INTIO, Inc., Galil Medical Ltd., Boston Scientific Corporation, SonaCare Medical, LLC, EDAP TMS S.A., Erbe Elektromedizin GmbH, IceCure Medical Ltd., MISONIX Inc., Endocare Inc., CooperSurgical Inc. and B V M Meditech Pvt.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Tumor Ablation Market to Grow at 10.4% During 2025-2033, Stimulated by Advent of Advanced Procedures
Purchase Options
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials